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Abstract
Background: Antiretroviral treatment services delivered in hospital settings in Africa increasingly lack capacity to
meet demand and are difficult to access by patients. We evaluate the effectiveness of nurse led primary care based
antiretroviral treatment by comparison with usual hospital care in a typical rural sub Saharan African setting.
Methods: We undertook a prospective, controlled evaluation of planned service change in Lubombo, Swaziland.
Clinically stable adults with a CD4 count > 100 and on antiretroviral treatment for at least four weeks at the district
hospital were assigned to either nurse led primary care based antiretroviral treatment care or usual hospital care.
Assignment depended on the location of the nearest primary care clinic. The main outcome measures were clinic
attendance and patient experience.
Results: Those receiving primary care based treatment were less likely to miss an appointment compared with
those continuing to receive hospital care (RR 0·37, p < 0·0001). Average travel cost was half that of those receiving
hospital care (p = 0·001). Those receiving primary care based, nurse led care were more likely to be satisfied in the
ability of staff to manage their condition (RR 1·23, p = 0·003). There was no significant difference in loss to follow-
up or other health related outcomes in modified intention to treat analysis. Multilevel, multivariable regression
identified little inter-cluster variation.
Conclusions: Clinic attendance and patient experience are better with nurse led primary care based antiretroviral
treatment care than with hospital care; health related outcomes appear equally good. This evidence supports
efforts of the WHO to scale-up universal access to antiretroviral treatment in sub Saharan Africa.
Background
Antiretroviral treatment (ART) has become increasingly
available to patients with HIV/AIDS in sub Saharan
Africa. The unfamiliarity of these new and potentially
toxic drugs has, for the most part, limited their use to
hospital-based, secondary care specialist clinics.
Secondary care can be difficult to access for poor rural
populations and, in many countries, lacks the capacity to
cope with the expanding numbers of patients on ART
follow-up care. The ultimate goal of many national ART
programmes is, therefore, to promote primary care and
community based ART.
There are an estimated 2·7 million new HIV infections
globally each year. Despite rapid progress, the universal
access goals remain far off. In low- and middle-income
countries in 2007 only 31% of people estimated to be in
need of treatment were receiving it [1]. Achieving uni-
versal access on such a major scale will depend on shift-
ing skills from hospital to primary care settings.
Primary care and community based ART programmes
have been implemented in highly resourced and
research contexts [2,3]. The safety and effectiveness of
such programmes in typical African district settings
remain uncertain. The potential threat of ART drug
resistance from poor adherence and monitoring in such
programmes is a particular concern [4,5].
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yearly HIV counselling and testing (HCT) and immedi-
ate ART, as a means to eliminate HIV [6]. The safety
a n de f f e c t i v e n e s so fp r i m a r yc a r ec l i n i cn u r s ea n dl a y
worker HCT and ART follow-up care is critical to the
feasibility of such an approach [7].
This study reports the results of a prospective, con-
trolled evaluation of nurse led, primary care based ART
in a rural African district on attendance and health
outcomes.
Methods
Setting
Lubombo is a predominantly rural region of Swaziland.
It has a population of 250,000 and one of the highest
prevalence rates of HIV in the world with 26% of those
aged 15-44 infected with HIV [8]. The region has one
district general hospital, two health centres and a net-
work of 30 nurse-run primary care clinics.
Study design
An evaluation of planned service change was undertaken
with a prospective cohort and control group compari-
son. A phased approach was taken following recommen-
dations for evaluations of complex interventions [9,10].
A piloting phase was undertaken May to December
2006 to assess feasibility and early implementation. The
study reported on here followed refinement of the pro-
tocol and wider testing, with recruitment from January
2007 to June 2007 and follow-up until November 2007.
Study population
Adults (aged over 14) on ART for at least four weeks
who had a CD4 count over 100 were included in the
study once they were assessed as clinically suitable for
nurse led follow-up by a medical officer. Children were
not included within the evaluation as more detailed clin-
ical and social assessment was undertaken before trans-
fer to the primary care centre.
The intervention group included patients receiving
A R Tw h or e s i d e do rw o r k e dw i t h i nt h ec a t c h m e n ta r e a
of the intervention clinics. The control population con-
sisted of adult patients who resided within the catchment
area of the control clinics (see Figure 1). Individuals who
would otherwise be eligible for the study who died before
their next scheduled appointment were not included in
the analysis as they would have had no opportunity to
take up the intervention.
Selection of primary care sites
Primary care centres were purposively selected for invol-
vement in the ART programme. For the pilot phase
seven primary care centres in close geographical proxi-
mity and with good clinical links were selected to
provide a favourable context for initial implementation.
For the main study an additional eight primary care cen-
tres were selected on the basis of being most remote
from the main hospital, providing a contrast to the pilot
sites and increasing the representativeness of these sites.
The control sites were the remaining eleven primary
care clinics in the region with patients participating in
the ART programme.
Intervention
The primary care based ART programme consisted of
an initial training programme for primary care centre
nurses developed by the hospital team, followed by a
monthly outreach support visit.
Patients attending the hospital ART programme who
fulfilled the inclusion criteria were assigned to interven-
tion or control groups depending on their nearest clinic.
Those in the intervention group were then offered pri-
mary care centre follow up. Patients could continue
treatment at the hospital if that was their preference.
An outreach team of at least one counsellor and nurse
provided monthly visits to each of the primary care
clinics. During these visits they undertook clinical
review, CD4 count and other appropriate investigations,
Figure 1 Map of clinics included in study.
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Complications such as side effects of medication and
opportunistic infections were managed at the clinic
where possible. If required, patients were referred for
further assessment and management at the main hospi-
tal site. Over the first seven months of the study pri-
mary care clinic nurses and lay support workers
increasingly took over ART review and ongoing adher-
ence counselling, and the hospital staff role became to
supervise and assist. During the study six clinics essen-
tially managed their own patients, whereas nine clinics
continued to rely on the hospital team for much of the
clinical care.
Outcome measures
The primary outcome measure was clinic attendance.
Clinic attendance was treated as a binary outcome: the
proportion of individuals attending all scheduled clinic
appointments was compared with the proportion of
individuals failing to attend at least one scheduled clinic
appointment. Arriving after the date of the scheduled
appointment was considered a failure to attend. Second-
ary outcomes included patient experience, loss to fol-
low-up (failing to attend a scheduled clinic appointment
for over 90 days; loss to follow-up was not considered
as missing an attendance under the primary outcome),
and change in health related outcomes (CD4 count,
weight, and death). Change in CD4 count and weight
were assessed by comparing the most recent CD4 and
weight before enrolment in the study to the last mea-
sured during the study.
Data collection and analysis
Patient outcomes were collected through the computer
based national ART monitoring and evaluation system.
This system is the key administrative database for sche-
duling clinic attendances and ensuring patient records
are available on the correct clinic day and site.
Outcomes among those in the intervention group
were compared with outcomes among those in the con-
trol group. Separate analyses were undertaken for those
who took up the intervention offered (per protocol) and
all those offered the intervention irrespective of whether
they took it up (modified intention to treat). Bivariate
analysis was undertaken using the Chi square test, Fish-
er’s exact test, two tailed t-test for comparison of means
or Kruskal-Wallis test as appropriate. The analysis plan
included multilevel multivariable logistic regression
modelling to provide an estimate of the clustering effect:
patients clustered within health centres; and that of
other variables. Modelling was undertaken for the pri-
mary outcome, clinic attendance, and included sex, age,
clinical stage on initiation of ART, most recent weight
at start of the study and whether or not an individual
was within the intervention or control group. This
model was programmed in Stata version 10 (StataCorp
2007).
Sample size
Assuming an individual had a probability of missing an
appointment during the period of follow-up of 0·3 we
wished to detect a reduction to 0·15 with intervention.
Given a ratio of intervention to control of 2:1, alpha =
0.05, power = 80% yields a sample size of 103 in the
control and 206 in the intervention groups. Assuming
an average of 15 patients per primary care centre then a
rough approximation of design factor with intracluster
coefficient = 0·01 is 1·14 yielding a sample size of 118
controls and 235 intervention groups.
Assessment of patient experience
Structured interviews were carried out between July and
August 2007 to assess satisfaction with services. Patients
enrolled into intervention or control groups by the 1
st
April 2007 were randomly selected for interview. The
intervention group was stratified by clinic site before
randomisation to ensure appropriate representation
from each site. Interviews were undertaken by two
trained interviewers for whom siSwati was their native
language and who were not hospital staff. Satisfaction
was rated using a Likert scale.
Ethics
Ethical approval was obtained from the Leeds University
Faculty of Medicine and Health Research Ethics Com-
mittee. The study was undertaken with agreement from
the Swaziland Ministry of Health. This was an evalua-
tion of planned service change. Consent for transfer to
nurse led primary care based antiretroviral treatment
was sought from those in the intervention group. Con-
sent was sought verbally by the assessing physician and
recorded by the physician in a written proforma. No
personally identifiable data was shared beyond the clini-
cal team.
Results
582 (80%) of the 734 individuals assessed for the study
were eligible (Figure 2). A quarter of those offered the
intervention refused. The most common reasons for
refusal were concern over stigma (23% of men; 37% of
women) and not convenient due to work location (50%
of men; 16% of women); other reasons included not
convenient due to home location; preference for hospi-
tal; and the patient receiving other medical treatment at
the hospital site.
Participants in intervention and control groups were
similar at the start of the study in terms of age, gender,
mean CD4 count, mean weight and proportion with
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entering the study was greater in the control group
(Table 1). The average length of time in the study was
25 days longer for the intervention group (267 days)
than the control group (242 days, p < 0.001). Similarly
the average number of clinic attendances after recruit-
ment was greater in the intervention group (7.1) than
the control group (6.1, p < 0.001).
Those in the intervention group were less likely to
miss an appointment; but showed no significant differ-
ence in proportion lost to follow-up. Although there
were significantly fewer deaths in the intervention
group, this effect was not seen when those who refused
intervention were included (modified intention to treat
analysis; Table 2). There was no significant difference in
other health outcomes measured (Table 3). The time
between measurements was longer for the control group
than the intervention group for weight (244 and 234
days respectively, p = 0.02) but not significantly different
for CD4 count (359 and 340 days respectively, p = 0.2).
Multilevel, multivariable modelling
In fitting a multilevel logistic regression of ‘any missed
appointment’ on all covariates there was very little varia-
tion at the primary care clinic level (p = 0·47). Being in
the intervention, rather than the control group, was the
only variable significantly associated with clinic atten-
dance in this model (odds ratio 0.3, 95% confidence
intervals 0.18-0.49, p < 0.0005).
Patient experience
No individual refused to participate in the study. Some
of those selected for interview were not included as
either the individual did not attend on the day of their
scheduled appointment or, in a small number of cases,
the individual had left the department before being
identified by the interviewers. Of those initially selected
for interview 74% (45) in the intervention group and
79% (44) in the control group underwent interview.
The average age was 36·8 for the intervention group
and 39·2 for the control group (p = 0·18) and 26% of
the intervention group were male, as compared with
36% of the control group (p = 0·31). Fewer of those
from the intervention group had obtained high school
education (p = 0·002).
Cost of travel
In the intervention group the average cost of return
transport for follow up care (0·74US$) was half that of
those in the control group attending hospital (1·5US$),
p = 0·001. Fifty-three per cent of those attending the
intervention clinic said that the cost of travel was
reduced by the intervention.
Satisfaction with services
Most patients from both intervention and control
groups were satisfied with most aspects of service
(Table 4). Levels of satisfaction were higher among the
intervention group for all aspects of satisfaction
734 assessed
109 not eligible
29 outside study area
11 inadequate study information
582 eligible
425 from intervention clinic areas 157 from control clinic areas
108 refused 
intervention
317 accepted 
intervention
3 died before next appointment date 
and excluded from analysis*
*All three were from control areas
Figure 2 Flow diagram of eligibility for study.
Table 1 Characteristics of participants
Intervention
(317)
Control
(157)
P value
Female (%, n) 67% (212) 68% (106) 0.9
Age (years, mean, standard deviation) 39.3 (10.9) 40.0 (11.8) 0.7
CD4 (most recent, mean, standard deviation) 373 (204) 407 (206) 0.2
Weight (kg, most recent, mean, standard deviation) 62.7 (10.9) 64.8 (12.4) 0.07
Stage IV at start of ART (%, n) 20% (64) 22% (35) 0.6
Time on ART at start (days, mean, standard deviation) 347 (278) 506 (334) < 0.0001
Length of follow-up (days, mean, standard deviation) 267 (48) 242 (53) < 0.0001
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tion in the ability of staff to manage the patient’sc o n d i -
tion. After adjusting for education there was no
significant difference in satisfaction (p = 0·96).
Those attending the intervention clinics were asked
how satisfied they were with attending the intervention
clinic rather than the main hospital site for ART (all
had previously attended the main hospital site for ART
in accordance with the protocol). Of those providing a
response (31; 69%): 81% (25) were very satisfied, 13% (4)
were satisfied, 3% (1) were dissatisfied and 3% (1) were
very dissatisfied.
When asked the reason for their level of satisfaction
attending the intervention clinic rather than the main
hospital site 72% (21) of those satisfied or very satisfied
volunteered reduced cost as a reason. Other reasons
given included being nearer to home, a shorter queue,
being treated better by staff, receiving better care and
that they would not be talked about at the intervention
clinic. The two individuals dissatisfied/very dissatisfied
cited as their reason the lack of a doctor at the interven-
tion clinic saying they did not have the money to attend
the main clinic, and delay because the team from
the hospital arrived late at the intervention clinic,
respectively.
Discussion and conclusions
This service evaluation demonstrated outcomes from a
nurse led primary care setting that are as good as or better
than in the traditional hospital setting. International gui-
dance has encouraged a public health approach to HIV
care, and in particular decentralising HIV services into the
community and integrating HIV prevention, treatment
and care services within primary care in generalised epi-
demics [11]. There has been little evidence to support the
efficacy or safety of this approach. This study demon-
strated providing ART in the primary care setting reduces
patient cost and increases attendance at scheduled
appointments. There is a common concern by health staff
that patients would fear a lack of competence or confiden-
tiality at their local nurse led primary care centre. How-
ever, patients demonstrate high levels of satisfaction with
services in the primary care setting. In spite of the lack of
diagnostics, such as radiology, or medical opinion available
on demand, patients were more satisfied in the ability of
staff to manage their condition in the local clinic setting
than the hospital setting. The lower educational attain-
ment of those interviewed in the intervention group, com-
bined with the fact that those who refused the
intervention could not be included may contribute to a
higher satisfaction rating among the intervention group.
Table 2 Key outcome measures
Intervention group Control group Relative risk 95% confidence intervals P value
n % n %
Per protocol analysis
Any missed appointment 33 10·4 44 28 0·37 (0·25 to 0·56) < 0·0001
Loss to follow-up 9 2·8 2 1·3 2·23 (0·49 to 10·19) 0·4
Died 0 0 4 2·5 0 (undefined) 0·01
Modified intention to treat analysis
Any missed appointment 50 11·8 44 28 0·42 (0·29 to 0·60) < 0·0001
Loss to follow-up 10 2·4 2 1·3 1·85 (0·41 to 8·34) 0·5
Died 4 0·9 4 2·5 0·68 (0·34 to 1·37) 0·2
Table 3 Other outcome measures
Valid result Change in measure
Intervention Control
n % n % Intervention Control P value
Per protocol analysis
Weight change (kg, mean) 314 99% 156 99% 1·18 1·04 0·8
CD4 change (cells per microlitre; mean) 122 38% 56 36% 103 85 0·7
Modified intention to treat analysis
Weight change (kg, mean) 419 99% 156 99% 1·09 1·04 0·9
CD4 change (cells per microlitre; mean) 122 38% 56 36% 101 85 0·6
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tion into planned service development and so provides
evidence of how the intervention works in a real world
rural Africa setting rather than in a heavily resourced
research conditions [12].
Intervention and control groups were allocated purpo-
sively. Cluster randomised introduction of the interven-
tion was considered politically not acceptable by health
service managers. Control and intervention groups were
similar in weight and CD4 counts. Viral loads were not
available for comparison between the groups as the
study relied on normal clinical facilities.
A minimum of one month of ART was required for
consideration for inclusion in the study. However, many
of the patients recruited had been on treatment much
longer than this (347 or 506 days on average for inter-
vention and control groups) when recruited to the
study. Those in the intervention group were on ART for
a shorter duration than the control group. The inclusion
of patients in the earlier stage of treatment, when
defaulting and morbidity is higher, would be expected to
worsen study outcomes [13]; to the contrary, outcomes
were as good or better in the intervention group.
The intervention group had a longer average period of
follow-up in the study than the control group. Having a
longer period in the study gives a greater potential for
adverse outcomes, particularly missed appointments,
loss to follow-up or deaths. However, again the out-
comes were as good or better in the intervention group
suggesting the effectiveness of the intervention may be
underestimated.
A number of studies have demonstrated good outcomes
from ART in primary care settings [3,14-18]. An ecological
approach has also been taken, describing mortality in
populations where primary care based ART has been
introduced [19]. However, none of these studies used a
suitable comparison group in order to assess the outcomes
against standard care. Community or primary care based
ART outcomes are likely to be incomparable with stan-
dard hospital based outcomes. Unlike community based
therapy, hospital registers are likely to include patients
admitted severely ill who commence ART as an inpatient.
While our study was not a randomised controlled
trial, it did include prospective recruitment of patients
who met stated physician-assessed criteria and a combi-
nation of patient-centred, clinical and service outcomes.
This is the only such prospective controlled study of
ART scale up in resource limited settings of which we
are aware.
A quarter of those offered primary care based ART
preferred to stay at the hospital. This was often due to
convenience, e.g. due to work location; while others
were concerned about the potential for stigmatisation
through attendance for HIV treatment in their own
community setting. When shifting care from hospital to
primary care settings service planners should assess and
cater for the wishes of a minority of patients who may
wish to access treatment outside their own community.
This study had minimum requirements for CD4 count
and time on treatment as well as clinical assessment of
patients before referring for nurse led follow-up. There
were very close links between the clinics and the hospi-
tal team throughout the study. Furthermore, the study
did not evaluate more complex aspects of patient care
such as drug toxicities, opportunistic infections or treat-
ment failure. There is a continued need for ready access
and appropriate referral to more specialised clinical care
for those receiving nurse led primary care based ART.
This study provides supporting evidence for the WHO
recommendations for decentralisation of HIV care [1].
Achieving universal access to ART will require the
transfer of services from overloaded hospital services to
primary care settings for the benefit of both patients
and staff. This transfer will depend on the shift of skills
and training from doctors to nurses, and some tasks to
lay workers. As delivery of ART care shifts from hospital
to primary care settings systems need to address staffing
and resources at the primary care level. The potential
impact on existing primary care services including capa-
city, motivation, recruitment of staff and other service
priorities needs to be further assessed. Further research
is required to explore the feasibility and effectiveness of
initiation of ART in a typical African community
setting.
Table 4 Proportion satisfied or various satisfied with aspects of clinic and service
Intervention
%( n)
Control
%( n)
RR 95% CI P value
Environment such as space, comfort at the clinic* 79·5% (35) 73·8% (31) 1·08 0·85-1·36 0·52
Ability of the staff to manage your condition
† 100% (44) 81·4% (35) 1·23 1·06-1·42 0·003
That your confidentiality will be maintained by clinic staff 77.8% (35) 77·3% (34) 1·01 0·80-1·26 0·95
Confidentiality will not be breached by other people seeing you at clinic
‡ 31·8% (14) 18.2% (8) 1·75 0·82-3·75 0·14
Overall service in this clinic 82·2% (37) 65·9% (29) 1·25 0·97-1·61 0·08
*3 non responses;
† 2 non-responses;
‡ 1 non-response
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universal yearly HIV counselling and testing (HCT) and
immediate ART, as a means to eliminate HIV [6]. This
study shows that primary care clinic nurse and lay
worker HCT and ART follow-up care can be safe and
effective, which is critical to the feasibility of such an
approach [7].
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